Table 1 Oncogenic/tumor-suppressive role of YTH domain-containing proteins in various human cancers.

From: Insight into the structure, physiological function, and role in cancer of m6A readers—YTH domain-containing proteins

Proteins

Role in diseases

Cancer

Intersection molecules and/or pathway

References

YTHDF1

OG/TS

LUAD

YAP; MALAT1-miR-1914-3p-YAP axis

[104, 113]

YTHDF1

OG

GC

Wnt/PI3K-AKT pathway; FZD7-β-catenin axis

[110, 111]

YTHDF1

OG

BC

ITGA6

[105]

YTHDF1

OG

CRC

TCF7L2/TCF4, c-MYC; Wnt/β-catemin

[38, 70, 144]

YTHDF1

OG

GBM

hsa-mir-346

[78]

YTHDF1

OG

CC

PDK4

[36]

YTHDF1

OG

HCC

FZD5

[111]

YTHDF1

TS

OM

HINT2

[39]

YTHDF1

OG

OSCC

METTL3/m6A/ YTHDF1/c-Myc axis

[43]

YTHDF1

OG

OC

EIFC3

[35]

YTHDF1

OG

PC

TRIM44

[145]

YTHDF2

OG/TS

LUAD

YAP

[113]

YTHDF2

OG

BC

SETD7/KLF4 axis

[57]

YTHDF2

OG

CC

LncRNA GAS5

[146]

YTHDF2

OG

CRC

LncRNA XIST, YPEL5; SOX4

[59, 147]

YTHDF2

OG

GBM

EGFR/SRC/ERK pathway

[52]

YTHDF2

TS

HCC

SOC2, EGFR, IL11, SERPINE2

[101, 112]

YTHDF2

OG

PDAC

YAP

[148]

YTHDF2

OG

AML

TNFRSF2

[149]

YTHDF2

OG

PC

METTL3/YTHDF2/LHPP/NKX3-1; MOB3B

[56, 74, 75]

YTHDF3

OG

BC

ITGA6

[105]

YTHDF3

OG

BRC

ST6GALNAC5, GJA1, EGFR

[130, 150]

YTHDF3

OG

CRC

GAS5-YAP-YTHDF3 axis;

[146]

YTHDF3

OG

HCC

Zeb1; ITGA6

[132, 151]

YTHDF3

OG

LUAD

MALAT1-miR-1914-3p-YAP axis

[104]

YTHDC1

OG

UCEC

 

[152]

YTHDC2

TS

LUAD

SLC7A11

[153]

YTHDC2

TS

CRC

HIF-1α

[154]

  1. OG oncogene, TS tumor suppressor, LUAD lung adenocarcinoma, GC gastric cancer, BC bladder cancer, CRC colorectal cancer, GBM glioblastoma, CC cervical cancer, HCC hepatocellular carcinoma, OM ocular melanoma, OSCC oral squamous-cell carcinoma, OC ovarian cancer, PC prostate cancer, PDAC pancreatic ductal adenocarcinoma, AML acute myeloid leukemia, BRC breast cancer, UCEC uterine corpus endometrial carcinoma.